drugset / Trial / NCT00609895

The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing

NCT00609895 ↗

Phase 4 Completed 22 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To compare the percentage of subjects with a glucose measurement \< than or = to 56 mg/dL at any point of the 8-point glucose profiles during 3 consecutive days before vs. 3 consecutive days after switching insulin glargine dosing time from bedtime to morning and vs. 3 consecutive days after switching back to bedtime dosing of insulin glargine.

Timeline

Start
2004-01
Primary completion
—
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic — —

Indications